Skip to main content

Table 1 – Sample’s characteristics and results of physician assessment, control questionnaires and lung function tests

From: Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time

  1stvisit n = 62 2ndvisit n = 61
Gender Female n (%) 37 (60) 36 (59)
Age mean (SD) years 39.6 (14.5) 39.8 (14.5)
Physician assessment n (%)   
 Asthma severity   
  Intermittent 12 (19) 7 (12)
  Mild persistent 21 (34) 16 (28)
  Moderate persistent 24 (39) 27 (48)
  Severe persistent 5 (8) 7 (12)
 Rhinitis classification   
  Intermittent 15 (28) 16 (34)
  Persistent 38 (72) 31 (66)
  Mild 27 (51) 26 (58)
  Moderate/severe 26 (49) 19 (42)
 Control   
  Both controlled 24 (39) 33 (59)
  Only asthma controlled 15 (24) 8 (14)
  Only rhinitis controlled 8 (13) 6 (11)
  Both uncontrolled 15 (24) 9 (16)
 Treatment decision   
  Reduce 3 (5) 2 (4)
  Maintain 29 (47) 42 (75)
  Increase 30 (48) 12 (21)
ACQ5 score median (P25-P75) 1 (0.2-2.5) 0.8 (0-2.2)
  <0.5 n (%) 22 (35) 26 (42)
  0.5–1.5 n (%) 14 (23) 12 (20)
  >1.5 n (%) 26 (42) 23 (38)
VAS* median (P25-P75)   
  All symptoms 5 (2-7) 4 (2-6.5)
  Bronchial/pulmonary symptoms 4 (2-7) 3 (2-6)
  Nasal symptoms 5.7 (3-8) 3 (2-7)
Lung function mean (sd)#   
  FVC 102 (17.1) 100 (20.8)
  FEV1 92 (19.7) 90 (23)
  PEF 89 (25) 88 (26.7)
F e NO 50 ª 30 (23.1) 24 (21.7)
  1. ACQ5 – Asthma control questionnaire (5-question); VAS – visual analogue scale; FVC – forced vital capacity; FEV1 – forced expiratory volume in 1 second; PEF – peak expiratory flow; Fe NO50- fractional exhaled nitric oxide.
  2. *1-10, 1 being no disturbance; # 1st visit n = 55; 2nd visit n = 53; ª 1st visit n = 23; 2nd visit n = 31.